Enveric Biosciences Inc (ENVB)

$0.88 0.03 (3.18%)

16:00 EDT ENVB Stock Quote Delayed 30 Minutes

ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q4 2023

By InvestorPlace Earnings Apr 1, 2024

ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 82,051

Day's Range $0.88 - $0.96

52-Week Range $0.65 - $6.98

Dividend & Yield N/A (N/A)

ENVB Stock Predictions, Articles, and Enveric Biosciences Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 19, 2023

It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?

By Josh Enomoto, InvestorPlace Contributor May 18, 2023

Enveric Biosciences’ Notice of Allowance for a therapeutic patent is bolstering ENVB stock, but investors should exercise caution.

The 7 Most Promising Psychedelic Stocks to Buy in February

By Muslim Farooque, InvestorPlace Contributor Feb 5, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

7 Psychedelics Stocks to Buy for a Big Drug Boom

By Tezcan Gecgil, InvestorPlace Contributor Aug 30, 2022

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

7 Short-Squeeze Stocks to Put on Your Must-Watch List

By Josh Enomoto, InvestorPlace Contributor Aug 16, 2022

If you want to zig while the bears zag, these short-squeeze stocks to put on your radar may make for handsome profits.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Aug 8, 2022

Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Aug 4, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 20, 2022

Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 24, 2021

We're kicking off another exciting week of trading with a look at the biggest pre-market stock movers for Monday morning.

5 Reddit Cryptos Seeing the Most Chatter Friday

By William White, InvestorPlace Writer May 21, 2021

It's another busy day of trading and where would we be without Reddit rising interest in various penny stocks with its chatter?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 21, 2021

It's Friday and we're kicking it off right with a look at the biggest pre-market stock movers for the last day of trading this week!

ENVB Stock: Why Little-Known Enveric Biosciences is Soaring Today

By Brenden Rearick, InvestorPlace Financial News Writer Mar 10, 2021

Enveric (ENVB) stock has purchased the exclusive rights to research molecules that could lead to huge breakthroughs in CBD cancer treatment.

Psychedelic stocks gain after FDA priority review for MDMA therapy (NYSE:CYBN)

From Seeking Alpha Feb 12, 2024

The FDA priority review for an MDMA-linked therapy leads to a surge in shares of psychedelic medicine companies such as Mind Medicine (MNMD). Read more here.

Enveric Biosciences files to sell 2.24M shares for holders (NASDAQ:ENVB)

From Seeking Alpha Jan 11, 2024

Enveric Biosciences files a prospectus for the resale of 2.24M shares, clarifying it is not an offer to sell securities.

Enveric stock jumps 13% on pipeline update (NASDAQ:ENVB)

From Seeking Alpha Dec 28, 2023

Enveric Biosciences (ENVB) stock jumped 13% after the company announced it has chosen EB-003 as its new psychiatric drug candidate. Read more here.

5 Biotech stocks tapping into unmet mental health treatment needs

From MarketBeat Dec 20, 2023

Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.

Enveric Biosciences Reports Full-Year 2021 Financial Results

From Benzinga Apr 1, 2022

Enveric Biosciences files to sell 1.2M shares for holders (NASDAQ:ENVB)

From Seeking Alpha Nov 8, 2023

Enveric Biosciences' selling stockholder, Lincoln Park Capital Fund, plans to sell 1.3 million shares of common stock. Read more.

ADVERTISEMENT